John Hamer is Director of AbCellera Biologics Inc.. Currently has a direct ownership of 128,862 shares of ABCL, which is worth approximately $351,793. The most recent transaction as insider was on Sep 01, 2021, when has been sold 137,351 shares (Common Shares) at a price of $16.93 per share, resulting in proceeds of $2,325,352. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 129K
0% 3M change
0% 12M change
Total Value Held $351,793

JOHN HAMER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 01 2021
SELL
Open market or private sale
$2,325,352 $16.93 p/Share
137,351 Reduced 51.59%
128,862 Common Shares
Aug 31 2021
SELL
Open market or private sale
$2,756,901 $16.95 p/Share
162,649 Reduced 37.93%
266,213 Common Shares
JH

John Hamer

Director
Vancouver, A1

Track Institutional and Insider Activities on ABCL

Follow AbCellera Biologics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABCL shares.

Notify only if

Insider Trading

Get notified when an Ab Cellera Biologics Inc. insider buys or sells ABCL shares.

Notify only if

News

Receive news related to AbCellera Biologics Inc.

Track Activities on ABCL